ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,844Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 337

$1.04M Total Retail Price of All Prescriptions

Rank: 9 out of 337

236 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 236 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 236 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 4,243 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$151 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 360 294 1 2
ATORVASTATIN CALCIUM 262 200 2 7
OMEPRAZOLE 237 164 3 4
LEVOTHYROXINE SODIUM 191 139 4 5
CRESTOR 166 93 5 29
AMLODIPINE BESYLATE 145 125 6 3
SIMVASTATIN 144 88 7 1
OXYCODONE HCL 142 24 S2 8 63
HYDROCODONE-ACETAMINOPHEN 129 39 S3 9 13
METOPROLOL TARTRATE 129 102 9 6
NORVIR 125 24 11 187
ATENOLOL 109 86 12 10
SYNTHROID 108 90 13 41
HYDROCHLOROTHIAZIDE 107 103 14 9
CITALOPRAM HBR 104 90 15 17
ISENTRESS 102 24 16 272
PREZISTA 88 12 17 213
FUROSEMIDE 80 80 18 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 74 19 31
CYMBALTA 78 19 20 59
FLUTICASONE PROPIONATE 76 65 21 34
LIPITOR 75 55 22 33
SERTRALINE HCL 70 27 23 18
OXYCONTIN 69 0 S2 24 87
GABAPENTIN 66 38 25 20
PRAVASTATIN SODIUM 65 60 26 14
DILTIAZEM 24HR ER 64 56 27 76
LOSARTAN POTASSIUM 60 45 28 15
METFORMIN HCL 59 41 29 12
PROAIR HFA 58 25 30 38
ALENDRONATE SODIUM 58 45 30 19
ESCITALOPRAM OXALATE 56 51 32 66
SPIRONOLACTONE 56 29 32 100
PANTOPRAZOLE SODIUM 56 20 32 36
AMITRIPTYLINE HCL 54 17 R 35 75
ADVAIR DISKUS 53 42 36 44
ATRIPLA 53 12 36 263
FLUOXETINE HCL 51 39 38 57
CYCLOBENZAPRINE HCL 51 0 R 38 103
TRAMADOL HCL 50 24 40 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.